Home | Welcome to Contract Pharma   
Last Updated Friday, August 1 2014
Print

Chugai Pharma Appoints CMO



Published April 25, 2014
Related Searches: Pharma R&D Development CMO
Athos Gianella-Borradori, M.D. has been appointed chief medical officer of Chugai Pharma USA, LLC, a subsidiary of Chugai Pharmaceutical Co. of Tokyo, Japan, and member of the Roche Group.
 
Dr. Gianella-Borradori is pediatric hematologist-oncologist and executive with more than 20 years of international R&D experience focusing on translational research and clinical development of novel therapeutics. He has held senior R&D positions at Novartis, Crucell, Bavarian Nordic, Cyclacel, Merck Serono, and Clavis Pharma. 
 
Dr. Gianella-Borradori is responsible for all clinical activity in the U.S. and will provide leadership for scientific and translational committees in Japan at the parent company. He represents the company in relationships with the FDA, academia, clinical investigators and patient communities, and is responsible for increasing the awareness of Chugai to facilitate its expanding clinical activity in the U.S.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On